 Abraham Nussbaum
Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physician-Patient Relations | 6 | 2020 | 590 | 1.320 |
Why?
| | Religion and Medicine | 3 | 2019 | 33 | 1.290 |
Why?
| | Psychiatry | 3 | 2020 | 196 | 1.120 |
Why?
| | Antipsychotic Agents | 5 | 2017 | 215 | 1.040 |
Why?
| | Isoxazoles | 3 | 2012 | 55 | 0.990 |
Why?
| | Marijuana Smoking | 3 | 2014 | 249 | 0.930 |
Why?
| | Clergy | 3 | 2019 | 10 | 0.870 |
Why?
| | Internship and Residency | 3 | 2024 | 1265 | 0.850 |
Why?
| | Literature, Modern | 2 | 2014 | 2 | 0.840 |
Why?
| | Mental Disorders | 4 | 2020 | 1157 | 0.820 |
Why?
| | Schizophrenia | 4 | 2012 | 444 | 0.810 |
Why?
| | Spirituality | 1 | 2024 | 87 | 0.770 |
Why?
| | Vaccination Refusal | 2 | 2020 | 61 | 0.750 |
Why?
| | Palmitates | 2 | 2012 | 21 | 0.740 |
Why?
| | Medical Marijuana | 2 | 2014 | 122 | 0.730 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2020 | 232 | 0.700 |
Why?
| | Faith-Based Organizations | 1 | 2021 | 4 | 0.680 |
Why?
| | Vaccination | 3 | 2020 | 1423 | 0.670 |
Why?
| | Medicine in Literature | 3 | 2016 | 4 | 0.660 |
Why?
| | Cannabis | 3 | 2020 | 509 | 0.650 |
Why?
| | Marijuana Abuse | 2 | 2014 | 211 | 0.630 |
Why?
| | Physicians | 4 | 2024 | 952 | 0.590 |
Why?
| | Mass Vaccination | 1 | 2019 | 18 | 0.580 |
Why?
| | Smallpox | 1 | 2018 | 10 | 0.580 |
Why?
| | Philosophy, Medical | 1 | 2018 | 8 | 0.580 |
Why?
| | Smallpox Vaccine | 1 | 2018 | 23 | 0.570 |
Why?
| | Occupations | 1 | 2018 | 50 | 0.570 |
Why?
| | Motivational Interviewing | 1 | 2020 | 122 | 0.550 |
Why?
| | Professional Role | 1 | 2019 | 169 | 0.520 |
Why?
| | Hospitals, Psychiatric | 1 | 2017 | 28 | 0.510 |
Why?
| | Psychotic Disorders | 2 | 2017 | 185 | 0.500 |
Why?
| | Psychiatric Department, Hospital | 1 | 2016 | 12 | 0.470 |
Why?
| | Dronabinol | 3 | 2017 | 249 | 0.460 |
Why?
| | Leadership | 2 | 2019 | 401 | 0.450 |
Why?
| | Inpatients | 2 | 2017 | 550 | 0.450 |
Why?
| | Prescription Drug Diversion | 1 | 2014 | 13 | 0.430 |
Why?
| | Phytotherapy | 2 | 2013 | 74 | 0.430 |
Why?
| | Attitude to Death | 1 | 2014 | 75 | 0.410 |
Why?
| | Legislation, Drug | 1 | 2014 | 73 | 0.400 |
Why?
| | Patient Readmission | 2 | 2017 | 769 | 0.390 |
Why?
| | Marijuana Use | 1 | 2017 | 220 | 0.390 |
Why?
| | Practice Patterns, Physicians' | 2 | 2020 | 1369 | 0.370 |
Why?
| | Religion and Psychology | 1 | 2012 | 27 | 0.370 |
Why?
| | Writing | 1 | 2014 | 102 | 0.360 |
Why?
| | Psychoanalytic Therapy | 1 | 2011 | 13 | 0.350 |
Why?
| | Plant Preparations | 1 | 2011 | 37 | 0.340 |
Why?
| | Length of Stay | 1 | 2017 | 1348 | 0.330 |
Why?
| | Mental Health | 2 | 2020 | 795 | 0.330 |
Why?
| | Drug Approval | 1 | 2011 | 93 | 0.330 |
Why?
| | Depression | 1 | 2020 | 1573 | 0.330 |
Why?
| | Communication | 1 | 2016 | 975 | 0.310 |
Why?
| | Prescription Drugs | 1 | 2011 | 110 | 0.310 |
Why?
| | Residence Characteristics | 1 | 2012 | 376 | 0.300 |
Why?
| | Antidepressive Agents | 1 | 2011 | 250 | 0.300 |
Why?
| | Humans | 27 | 2024 | 145491 | 0.300 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2379 | 0.260 |
Why?
| | Suicide, Attempted | 1 | 2011 | 422 | 0.260 |
Why?
| | Paliperidone Palmitate | 3 | 2012 | 3 | 0.260 |
Why?
| | Mental Health Services | 1 | 2012 | 472 | 0.250 |
Why?
| | Suicide | 1 | 2014 | 728 | 0.240 |
Why?
| | Colorado | 5 | 2020 | 4572 | 0.230 |
Why?
| | Curriculum | 2 | 2024 | 1068 | 0.220 |
Why?
| | Alzheimer Disease | 1 | 2011 | 631 | 0.220 |
Why?
| | Courage | 1 | 2024 | 3 | 0.210 |
Why?
| | History, 20th Century | 2 | 2018 | 327 | 0.210 |
Why?
| | Pyrimidines | 1 | 2008 | 520 | 0.210 |
Why?
| | Cultural Competency | 1 | 2024 | 89 | 0.200 |
Why?
| | History, 21st Century | 2 | 2014 | 220 | 0.180 |
Why?
| | Risperidone | 2 | 2012 | 29 | 0.180 |
Why?
| | Education, Medical | 2 | 2016 | 273 | 0.170 |
Why?
| | Internal Medicine | 1 | 2024 | 279 | 0.170 |
Why?
| | Living Wills | 1 | 2020 | 9 | 0.160 |
Why?
| | Refusal to Treat | 1 | 2020 | 16 | 0.160 |
Why?
| | Observer Variation | 1 | 2020 | 358 | 0.150 |
Why?
| | Freedom | 1 | 2019 | 15 | 0.150 |
Why?
| | History, 18th Century | 1 | 2018 | 18 | 0.140 |
Why?
| | Vaccination Coverage | 1 | 2020 | 102 | 0.140 |
Why?
| | History, 19th Century | 1 | 2018 | 63 | 0.140 |
Why?
| | Science | 1 | 2018 | 56 | 0.130 |
Why?
| | Evidence-Based Practice | 1 | 2020 | 230 | 0.130 |
Why?
| | Trust | 1 | 2019 | 156 | 0.130 |
Why?
| | Anti-Anxiety Agents | 1 | 2017 | 47 | 0.130 |
Why?
| | Cues | 1 | 2019 | 329 | 0.120 |
Why?
| | Public Health | 1 | 2021 | 573 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2012 | 1755 | 0.110 |
Why?
| | Risk Factors | 3 | 2016 | 10874 | 0.110 |
Why?
| | Vaccines | 1 | 2019 | 388 | 0.100 |
Why?
| | Humanism | 1 | 2013 | 6 | 0.100 |
Why?
| | Male | 6 | 2018 | 72817 | 0.100 |
Why?
| | Female | 7 | 2017 | 78763 | 0.100 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 296 | 0.100 |
Why?
| | Odds Ratio | 1 | 2016 | 1082 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3424 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2017 | 11831 | 0.090 |
Why?
| | Pandemics | 1 | 2021 | 1706 | 0.090 |
Why?
| | Physical Examination | 1 | 2013 | 243 | 0.090 |
Why?
| | Psychoanalytic Interpretation | 1 | 2011 | 2 | 0.090 |
Why?
| | Dibenzothiazepines | 1 | 2011 | 18 | 0.090 |
Why?
| | Ethylene Glycol | 1 | 2011 | 15 | 0.090 |
Why?
| | Combined Modality Therapy | 2 | 2011 | 1269 | 0.090 |
Why?
| | Medicine | 1 | 2013 | 125 | 0.090 |
Why?
| | Drug and Narcotic Control | 1 | 2011 | 24 | 0.090 |
Why?
| | Adult | 4 | 2017 | 40707 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 6070 | 0.080 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1327 | 0.080 |
Why?
| | Drug Substitution | 1 | 2011 | 63 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2016 | 693 | 0.080 |
Why?
| | Comorbidity | 1 | 2016 | 1659 | 0.080 |
Why?
| | Hypercholesterolemia | 1 | 2011 | 95 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2014 | 8326 | 0.080 |
Why?
| | Benzodiazepines | 1 | 2011 | 168 | 0.080 |
Why?
| | Suicidal Ideation | 1 | 2016 | 577 | 0.080 |
Why?
| | Sex Factors | 1 | 2016 | 2110 | 0.080 |
Why?
| | Middle Aged | 3 | 2017 | 36176 | 0.070 |
Why?
| | Pain | 2 | 2013 | 787 | 0.070 |
Why?
| | Young Adult | 2 | 2017 | 14192 | 0.070 |
Why?
| | Quinolones | 1 | 2011 | 204 | 0.070 |
Why?
| | Piperazines | 1 | 2011 | 378 | 0.070 |
Why?
| | United States | 3 | 2019 | 16115 | 0.070 |
Why?
| | Adolescent | 2 | 2020 | 22485 | 0.070 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 147 | 0.070 |
Why?
| | Prevalence | 1 | 2014 | 2855 | 0.060 |
Why?
| | Delayed-Action Preparations | 1 | 2008 | 187 | 0.060 |
Why?
| | Neuropsychological Tests | 1 | 2011 | 1139 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1816 | 0.060 |
Why?
| | Child, Preschool | 1 | 2020 | 11837 | 0.050 |
Why?
| | Prospective Studies | 1 | 2016 | 8039 | 0.050 |
Why?
| | Government Regulation | 1 | 2019 | 39 | 0.040 |
Why?
| | State Government | 1 | 2019 | 46 | 0.040 |
Why?
| | Pennsylvania | 1 | 2019 | 138 | 0.040 |
Why?
| | Attitude to Health | 1 | 2019 | 431 | 0.030 |
Why?
| | Aged | 1 | 2014 | 26125 | 0.030 |
Why?
| | Spasm | 1 | 2013 | 21 | 0.020 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2013 | 39 | 0.020 |
Why?
| | Quetiapine Fumarate | 1 | 2011 | 26 | 0.020 |
Why?
| | Qualitative Research | 1 | 2019 | 1677 | 0.020 |
Why?
| | Aripiprazole | 1 | 2011 | 20 | 0.020 |
Why?
| | Pediatrics | 1 | 2019 | 1121 | 0.020 |
Why?
| | Diet, Reducing | 1 | 2011 | 91 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2011 | 359 | 0.020 |
Why?
| | Cholesterol | 1 | 2011 | 405 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2011 | 539 | 0.020 |
Why?
| | Triglycerides | 1 | 2011 | 518 | 0.020 |
Why?
| | Risk | 1 | 2011 | 917 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1058 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 970 | 0.020 |
Why?
| | Body Mass Index | 1 | 2011 | 2425 | 0.010 |
Why?
| | Exercise | 1 | 2011 | 2192 | 0.010 |
Why?
| | Animals | 1 | 2013 | 38141 | 0.000 |
Why?
|
|
Nussbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|